Medication Guidelines for Uremia
Uremia is a relatively severe condition that often causes hepatic damage and may even endanger life. What is the pharmacological approach to treating uremia?
Pharmacological Management of Uremia
In managing uremia, blood pressure control is a primary concern. First-line antihypertensive agents typically include beta-blockers and calcium channel blockers—representative examples being nifedipine sustained-release tablets and metoprolol. Following initiation of dialysis therapy, renin-angiotensin-aldosterone system (RAAS) inhibitors—such as moexipril or aliskiren—may be added. To regulate calcium-phosphate metabolism and manage secondary hyperparathyroidism, medications such as lanthanum carbonate, sevelamer, calcitriol, potassium citrate, and calcium acetate may be prescribed. Sodium bicarbonate injection or oral tablets are commonly co-administered to correct acid-base imbalances.

Uremia arises from multiple etiologies, broadly categorized as pre-renal and post-renal causes, as well as intrinsic renal disease. Intrinsic renal factors involve pathological processes affecting the glomeruli, renal tubules, renal vasculature, or renal interstitium—all potentially leading to renal failure. Pre-renal causes commonly include reduced intravascular volume resulting in renal hypoperfusion. Post-renal causes primarily involve urinary tract obstruction, frequently due to urolithiasis or neoplastic lesions.

Maintain regular daily routines and avoid frequent late-night activity; ensure adequate sleep duration. Diet should be light and easily digestible, minimizing intake of greasy or spicy, irritating foods. Emphasize consumption of fresh vegetables and fruits rich in vitamins. We hope this information proves helpful to you!